Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
194
datasets available to search
ShareScore release 0.9.0
Dataset results
194 results for “active surveillance”
A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT06526624. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
ClinicalTrials.gov study NCT00482157. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Effects of Active Surveillance Protocol on Long Term Quality of Life in Patients With Mild Pericoronitis
ClinicalTrials.gov study NCT03027622. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance
ClinicalTrials.gov study NCT03495479. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Active Surveillance Cultures for Multidrug Resistant Gram-Negative Organisms at an Acute Care Hospital
ClinicalTrials.gov study NCT04715464. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Active Surveillance for Prostate Cancer With Indolent Features
ClinicalTrials.gov study NCT00421265. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.
ClinicalTrials.gov study NCT06971965. IPD Sharing: NO. Countries: 0. Publications: 0.
Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.
ClinicalTrials.gov study NCT00584532. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Development of Active Safety Surveillance System for Traditional Chinese Medicine
ClinicalTrials.gov study NCT00275964. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Comparison of Surgery and Active Surveillance in the Treatment of Bosniak III Renal Cysts
ClinicalTrials.gov study NCT04670887. IPD Sharing: YES. Countries: 0. Publications: 0.
Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer
ClinicalTrials.gov study NCT02179762. IPD Sharing: Not stated. Countries: 0. Publications: 0.
18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study
ClinicalTrials.gov study NCT05707182. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Surveillance Pathway Senses Leaked Mitochondrial DNA to Activate UPRmt and Promote Longevity
GEO Series GSE316187. Caenorhabditis elegans. 12 samples. Type: Expression profiling by high throughput sequencing.
Dataset related to article "Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study "
<p>This record contains raw data related to article “Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study"</p> <p>Abstract</p> <p><strong>Objectives: </strong> To test the hypothesis that patients under active surveillance (AS) for Non-muscle Invasive Bladder Cancer (NMIBC) who were negative on longitudinal re-testing by the Xpert<sup>®</sup> Bladder Cancer Monitor (Xpert BC Monitor) assay may avoid unnecessary cystoscopies and urine cytology (UC).</p> <p><strong>Subjects/patients or materials and methods: </strong> This is a prospective cohort study of patients enrolled in the AS protocol for recurrent NMIBC (Bladder Cancer Italian Active Surveillance, BIAS project), whose urine samples were analyzed by Xpert BC Monitor upon entry in the study (T0). Patients who had a negative Xpert test and did not fail AS, underwent additional Xpert tests after 4 (T1), 8 (T2), and 12 (T3) months. The clinical utility of Xpert was assessed by determining the number of cystoscopies and UC that could be avoided within 1 year.</p> <p><strong>Results: </strong> Overall, 139 patients were tested with Xpert at T0. Median follow-up was 23 (IQR 17-27) months. Sixty-eight (48.9%) patients failed AS, 65 (46.7%) are currently on AS, and 6 (4.3%) were lost at follow-up. At T0 57 (41.0%) patients had a negative test and 36 (63.2%) are still in AS. In patients with 2 consecutives negative Xpert tests, we could have avoided 73.9% of unnecessary cystoscopies, missing 26.4% failure, up to avoid all cystoscopies with 4 negative tests missing only 12% of failure. All the patients with negative Xpert had negative UC. Failure-free-survival at median follow-up (23 month) stratified for having 0, 1, or ≥2 negative tests was 67.0, 55.1. and 84.1, respectively.</p> <p><strong>Conclusion: </strong> Our findings suggest that Xpert BC Monitor assay, when it is longitudinally repeated, could significantly reduce the number of unnecessary cystoscopies and UC during their follow-up.</p> <p> </p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.